Leerink Partners
Crystal Zheng is an Investment Banking Associate at Leerink Partners, focusing on healthcare mergers and acquisitions, with notable transactions including ANI Pharmaceuticals' $275 million convertible senior notes offering and the $135 million sale of Xellia Pharmaceuticals' U.S. operations. Previous experience includes serving as a Private Equity Summer Analyst at Trinity Forest Partners and a Senior Fund Accountant at Standish Management, along with roles such as Chief Investment Officer at Smart Woman Securities and an Acquisition Finance Summer Analyst at ING. Crystal Zheng holds a Master's degree in Finance from Vanderbilt University and dual Bachelor's degrees in Finance and IT, as well as Psychology, from the University of Virginia. Additional educational experiences include programs in Europe and language studies in Barcelona.
This person is not in any offices
Leerink Partners
1 followers
Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority. SVB Securities LLC is doing business as Leerink Partners.